"Bang Bang Bang ......"

"Bang Bang Bang ......"

The scholars at the scene gave the warmest applause to Zhou Wenbao, which was very different from the sparse applause at the beginning.

Zhou Wen thanked him several times and nodded to the audience, and they all ushered in warm applause again.

After three times, the applause finally died down.

Zhou Wen said slowly: "As we all know, unlike healthy cells, cancer cells are constantly dividing and need to synthesize new DNA and RNA to support the production of new cells.

But our relentless research has found that early-stage lung cancer has an unexpected weakness that is particularly dependent on the pyrimidine biosynthesis pathway, and that a kind of lanthanase agent we call is effectively resistant to it in cell lines and mouse models......"

With Zhou Wen's speech, thousands of lung cancer experts and scholars in the audience gradually showed surprise on their faces.

"And with more in-depth research, we have made a breakthrough in the treatment of early-stage lung cancer!"

After a pause, as all the experts in the audience held their breath, Zhou Wen said: "Taking advantage of this weakness, we successfully resisted the invasion of early lung cancer and further effectively killed it. ”

As Zhou Wen spoke, the big screen behind him lit up, and an experimental data graph appeared on it.

Zhou Wen lowered his head and slid the iPad on the podium, and the data graph on the big screen also moved left and right.

Codenamed DST-104, this is the first simulation experiment three months ago, mainly targeting the more common mutated genes EGFR, ALK, cMET, ROS1, HER2, KRAS, etc...... This is the second animal experiment two months ago......"

With Zhou Wen's explanation, the scene was silent at first, but it gradually boiled.

Countless experts and scholars began to discuss it loudly.

"Didn't Dr. Aung Naing say that the response to anti-PD-1 monoclonal antibody alone is not good, why did he react the opposite?"

"Hey, you see, the gene sequence of this dihydroorotate dehydrogenase has changed. ”

"Why does this lanthanase react in such a strange way......

The experimental data released by Zhou Wen was like throwing a boulder under the calm surface of the lake, which instantly set off a monstrous wave.

The discussion of lung cancer experts at the scene is getting louder and louder.

Those medical professionals, representatives of pharmaceutical companies, and lung cancer patients who do not have a thorough understanding of lung cancer, although they cannot understand the complex theoretical knowledge and target maps, they understand Zhou Wen's words - early lung cancer can be completely cured.

"Is he telling the truth, that early lung cancer can really be completely cured?"

"No way, there was no news before. ”

"This man is a Gairdner Award winner, so he shouldn't be talking nonsense......"

Wu Yilong, who was sitting in the middle, was also very surprised at this time.

He was speculating before, how could Zhou Wen, a person who studies biological viruses, appear at the lung cancer conference, but he didn't expect that the other party really made a breakthrough in the field of lung cancer research.

"Teacher, how true is this data?" asked the assistant sitting next to Wu Yilong.

Wu Yilong looked at the experimental data on the big screen for a moment, and said in a solemn tone: "It's not certain for the time being, you need to do experiments to know." ”

After a pause for half a second, Wu Yilong said: "But this person is a medical wizard, and he has made brilliant achievements in oncology, and it is very likely that he is real." ”

The assistant looked at the data on the big screen with a shocked look on his face.

He has been researching lung tumors for 20 years, and although he has achieved outstanding results, most of them are based on foreign research results.

For example, Zhou Wen directly attacked early-stage lung cancer, especially small cell lung cancer, which accounts for 15% of the total number of lung cancers, due to the high degree of malignancy and limited treatment measures, so far, there is no approved targeted drug in the world.

Zhou Wen directly announced that it could be cured, which was simply terrifying.

And since it has a curative effect on early-stage lung cancer, it means that it must also have a fairly obvious effect on mid-stage and advanced lung cancer.

How is this not shocking?

The buzz of the scene is getting louder and louder.

Especially those tumor and lung oncology specialists, there are question marks in their stomachs at this time, but Zhou Wen has already stepped down from the podium.

The host, Ronald, after exchanging words with the people next to him, said, "Ahem...... First of all, thank you Professor Zhou Wen for your wonderful speech, just now Dr. Taylor and Professor Nicholas have said that they will leave 10 minutes for you to ask questions, Professor Zhou, you can see ......"

Zhou Wen, who had just walked to the seat, smiled when he heard this: "Okay......"

……

The news of the early stage of lung cancer has unsurprisingly quickly appeared in the mainstream media of major countries in the world, such as Singapore, China, France, Italy, Germany, and Russia.

Soon the United States, the United Kingdom, South Korea, Australia, New Zealand and other countries also reported one after another.

In private, countless lung tumor research institutes and pharmaceutical companies in Western countries were surprised and stunned after learning the news.

In terms of cancer treatment, research institutes in Western countries have always been at the forefront of the world, and every year they rely on the authorization of pharmaceutical agents to extract tens of billions of dollars in profits from China.

But I didn't expect that this time, Chinese pharmaceutical companies would take the lead in producing research results.

And those pharmaceutical giants in Europe and the United States were a little stunned at first, but when they saw Zhou Wen's name, the stunned look on their faces quickly returned to normal.

These pharmaceutical giants have a better understanding of Zhou Wen.

In addition to speeding up the development of new drugs, they also launched a more in-depth commercial investigation of Zhou Wen and Universal Biopharmaceutical.

On October 13th, Huanyu Biotech held its first press conference at the Taihu International Conference Center in Jiangzhou.

He mainly answered questions from reporters on issues such as HIV specific drugs, new allergy drugs, and new lung cancer drugs.

More than 1,600 journalists from more than 70 countries attended the press conference.

For the first time, Oneworld has stepped from behind the scenes to the forefront.

The press conference was broadcast live.

Luo Zongwei, vice president and director of the market operation department of Huanyu Biotech, answered more than 60 questions raised by reporters.

For the first time, many people learned about the scientific research strength of Huanyu.

For example, in its laboratory, there are more than 400 researchers with doctoral degrees, and more than 1,500 master's and undergraduate students graduated from key universities.

"Our investment in scientific research is also very huge, in the first half of 2020, the salary expenditure of personnel alone reached 750 million, and the experimental expenditure exceeded 2 billion. ”

"With such a painstaking investment, the output is naturally very gratifying. ”

"For example, those bio-ointments that have just been launched have very good efficacy for various skin diseases. For example, ichthyosis, folliculitis, scleroderma and psoriasis have been proven. ”

"And ......"

Taking the opportunity of the press conference, Luo Zongwei also lost no time in promoting the company's products......

The spotlight flickered at the press conference, and major pharmaceutical companies at home and abroad basically paid attention to the press conference.

Foreign Pfizer, Novartis, Roche, Mojiao, Sanofi, Gunshot, Gilead Sciences, GlaxoSmithKline, AbbVie, Amgen, AstraZeneca, Allergan and so on.

And domestic companies such as Hengrui, Maria, Yaoming KangDe, Ali Health, Yunan Pharmaceutical, Hengda Health, Sinopharm Holdings, Zhifei Biotechnology, Yaoming Biotechnology, CSPC Pharmaceutical Group and so on.

The previous scientific research results have made these company executives and shareholders envious and jealous.

And their talent pool also makes many domestic companies ashamed.

Of course, they know that the Ph.D. is good, and the students who graduated from key universities are smart, and the key is that they can't afford it.

A doctoral student, the annual salary should be at least two or three hundred thousand, right?

How much is ten?

How many are a hundred?

In addition, how much salary do master's and undergraduate students from key universities pay a year?

It's all money!

There are also experimental consumables and so on.

Such a huge investment in scientific research is also compared with those large pharmaceutical companies in China.

However, when Luo Zongwei talks about scientific research output, many people are dismissive and disdainful.

This is pure nonsense.

They acknowledge that pharmaceuticals are a high-input, high-output industry.

However, there is a problem here, pharmaceuticals do not pay off on investment.

If this is the case, domestic capital has already flocked to it, how can it be possible to engage in real estate?

……

Huanyu Biotech has made its debut, and its strength has surprised many domestic pharmaceutical companies.

Villa 108 Jiangnan Garden, basketball room.

Zhou Wen stood outside the three-point line and gently slapped the basketball, looking at the live broadcast of the press conference on the wall.

"Pong-Pong-Pong-"

When the conference resounded with warm applause, he smiled and threw it away, and the basketball drew a beautiful arc and fell into the basket.

The basketball did not roll out of the line or bounce to other places as expected, but bounced on the ground a few times, and happened to fall into Zhou Wen's hands.

After Zhou Wen slapped a few times, he threw it into the basket again, and then bounced into his arms again as if he had eyes.

Then he leaned over slightly, like an all-star game on TV, after doing a few fancy dribbles to the extreme, he rushed forward, and his body was directly raised by more than three meters, and most of his body had exceeded the basket.

After the body fell slightly, he held the basketball with both hands and poured it into the basket with a "bang"!

The chassis of the mobile basketball hoop couldn't withstand such a large amount of force, and after a few swayings, it fell to the side.

Zhou Wen's eyes were fast, and after running two steps, he supported the fallen basketball pillar with one hand and straightened it.

"Trash!"

Zhou Wen then threw the basketball into the basketball hoop by the wall, turned around and walked towards the door.

In front of the house is a small lotus pond, which has some precious goldfish, and a little civet cat is squatting on the edge of the lotus pond, its head is swimming with the goldfish, constantly turning, as if wondering, how to get one up to taste?

Zhou Wen walked over, the little civet cat glanced at him, and then "meowed", licked his mouth with his pink barbed tongue, and turned his head to look at the goldfish in the lotus pond "Meow Meow", as if to say: shovel, quickly catch one for me to eat.

Zhou Wen smiled, bent down to pick it up, stroked its head and smiled: "You leper cat still want to eat goldfish meat, people are much more expensive than you." ”

"Aim~" The tanuki cat struggled for a while, but didn't break free, so he rubbed his head Zhou Wen's neck.

"It's useless to be spoiled, eat your cat food!"

Zhou Wen smiled and stroked its head for a while, and then put it on the ground.

The tanuki cat rubbed on his leg again, and then walked to the lotus pond with cat steps, and looked condescendingly at the goldfish inside. It seems that he will not give up.

Zhou Wen smiled, didn't care about it, and walked along the path in front of the house to the large garden in the front yard.

The 11 a.m. sun shone on the face, a little harsh.

At this moment, there was a sound of footsteps behind her, and Sister Qiu, the nanny, came over with a caller.

Zhou Wen turned his head and asked, "Who?"

Sister Qiu, the nanny, glanced at the phone screen and said, "It shows that it's my sister-in-law." ”

"Ahh......h

Then I chatted a few words.

It didn't matter, just invited him to a birthday party in the evening.

"I just came back from Singapore yesterday and I'm a little tired, go ahead. ”

Chen Zhiyuan was not reluctant, and said: "That's okay! By the way, has the house over there in Jiangnan Garden been bought, I asked Mr. Tang, and she asked me to ask you myself." ”

There are very few people around Zhou Wen who know about buying a house, only Tang Xiaoli and Chen Zhiyuan, both of whom are very strict-mouthed.

Zhou Wen: "I bought it, I have time to come and see, the place is very big." ”

Chen Zhiyuan: "How big is it?"

Zhou Wen: "6500 square meters. ”

Chen Zhiyuan: "............"

After hanging up, he smiled, and suddenly it occurred to him that the task had not yet been submitted.

This trip to Singapore is also a serial mission.

Originally, he didn't plan to publish the results of lung cancer research so early, at least he had to brush up on a few SCI papers, but the system had a task, and he pushed the boat down.

The task was submitted after opening the system.

【Ding!Mission accomplished.】 Congratulations on earning 10,000 subject experience and 5,000 points. 】

【Ding!Mission accomplished.】 Congratulations on earning 20,000 subject experience and 10,000 points. 】

Then he looked at the personal stats bar.

Host: [Zhou Wen]

Occupation: [Senior Pharmacist;11580/100000]

True Eye: [LV3;1079/50000]

Main Disciplines:

Pharmacology:【LV6;0/200000】

Pathology: [LV6;0/200000]

Biological Immunology: [LV7;0/1000000]

Biochemistry: [LV6;0/200000]

Systematic Anatomy: [LV5;0/100000]

Linguistics: [(English) (German) (Latin) (Japanese) (Wu) (Cantonese) (Russian) (Korean)]

Subdiscipline:

Botany;【LV6;0/200000】

Zoology: [LV3;0/20000]

Psychology: [LV4;0/50000]

Discipline Experience: [175053]

Points:【313690】

The first is the pharmacist rank.

After a year of hard work, I was promoted to the next level, and I thought it would be even more difficult next.

I didn't expect to make an intermediate gene enhancer, but the upgrade is very fast, at this rate, I can upgrade to a master pharmacist in almost a year.

However, the premise is that the XP gain from crafting an Intermediate Pharmacist remains the same.

The second is the true eye.

During this time, the True Vision Eye has been upgraded from LV2 to LV3.

As expected, the nucleus can now be seen.

The nucleus of an atom is equivalent to the difference between an egg and a house.

In addition, the discipline of biological immunology has been upgraded, and he has a deeper understanding of genes and life.

This understanding can help him explore the nature of life and decipher the mysteries of genes.

After looking at it for a while, he opened his inventory and began to unpack the box......